BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25617937)

  • 1. The role of bioinformatics in diabetes drug development--and precision medicine.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E1. PubMed ID: 25617937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of translational bioinformatics approaches for pharmacology research.
    Li L
    Br J Clin Pharmacol; 2015 Oct; 80(4):862-7. PubMed ID: 25753093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for personalized medicine-based research and implementation in the clinical workflow.
    Lieb W; Völzke H; Pulley JM; Roden DM; Kroemer HK
    Clin Pharmacol Ther; 2012 Oct; 92(4):443-5. PubMed ID: 22910438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personalized medicine and type-2 diabetes: pharmakogenetic aspects of drug therapy].
    Barthel A; Schwarz P; Schindler C; Bornstein SR
    Dtsch Med Wochenschr; 2014 Feb; 139(6):234-6. PubMed ID: 24473838
    [No Abstract]   [Full Text] [Related]  

  • 6. Translational bioinformatics in psychoneuroimmunology: methods and applications.
    Yan Q
    Methods Mol Biol; 2012; 934():383-400. PubMed ID: 22933157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics and drug discovery.
    Lundstrom K
    Future Med Chem; 2011 Nov; 3(15):1855-8. PubMed ID: 22023028
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward personalized medicine in the neuropsychiatric field.
    Wong EH; Fox JC; Ng MY; Lee CM
    Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics in medicine: From promise to practice.
    Urban MF
    S Afr Med J; 2015 Sep; 105(7):545-7. PubMed ID: 26428748
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction to the theme "Precision medicine and prediction in pharmacology".
    Insel PA; Amara SG; Blaschke TF
    Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
    [No Abstract]   [Full Text] [Related]  

  • 11. How the science of personalized medicines will change the clinical management of patients in the pharmacy.
    Airley R; Evans A
    Future Med Chem; 2012 Oct; 4(16):2023-7. PubMed ID: 23157235
    [No Abstract]   [Full Text] [Related]  

  • 12. The application of next-generation sequencing technologies to drug discovery and development.
    Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
    Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can genetics improve precision of therapy in diabetes?
    Groop L; Storm P; Rosengren A
    Trends Endocrinol Metab; 2014 Sep; 25(9):440-3. PubMed ID: 25028244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q&A: Perry Nisen. Better insights, better drugs.
    Nisen P; Bender E
    Nature; 2015 Nov; 527(7576):S18. PubMed ID: 26536220
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD; Wagner JA
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational and systems medicine.
    Nielsen J
    J Intern Med; 2012 Feb; 271(2):108-10. PubMed ID: 22142230
    [No Abstract]   [Full Text] [Related]  

  • 18. Translational bioinformatics approaches for systems and dynamical medicine.
    Yan Q
    Methods Mol Biol; 2014; 1175():19-34. PubMed ID: 25150864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE: THE EXEMPLE OF TYPE 2 DIABETES].
    Paquot N
    Rev Med Liege; 2015; 70(5-6):299-305. PubMed ID: 26285456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of translational bioinformatics in drug discovery.
    Buchan NS; Rajpal DK; Webster Y; Alatorre C; Gudivada RC; Zheng C; Sanseau P; Koehler J
    Drug Discov Today; 2011 May; 16(9-10):426-34. PubMed ID: 21402166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.